From Gut Feeling to US Scaling: A Market Entry Strategy for BIOMEFIX Liquid Probiotics

Growing knowledge about human health, digestion, immunity, and the gut microbiome has changed the way consumers approach everyday well-being. People are increasingly informed and more open to preventive, science-based solutions, which creates new opportunities for microbiome-support products. This thesis aimed to assess the attractiveness and feasibility of the U.S. market for BIOMEFIX, a Slovak–Czech producer of liquid probiotic dietary supplements, and to propose a suitable market-entry mode and business model. As a first step, internal and external analyses were conducted to understand BIOMEFIX’s current strategic position and the broader U.S. market environment. This was followed by an assessment of regulatory requirements, customer segments, competitor dynamics, logistics options, operating configurations, business model options, financial assumptions, and key risks. The thesis also considered the specific characteristics of BIOMEFIX’s liquid product format, including its implications for shelf life, distribution, quality control, and customer access. The analysis showed that the U.S. market offers significant opportunities but also presents important regulatory, operational, financial, and competitive constraints. Based on these findings, the thesis develops a structured market-entry recommendation and outlines the conditions under which U.S. expansion could be considered feasible. The work concludes with a proposed staged entry logic, implementation priorities, and areas requiring further validation before scale-up.